Xiang Gao
Vermogen: 1 111 M $ op 30-09-2026
Vermogen: 1 111 M $ op 30-09-2026
Dr. Xiang Gao is an Independent Non-Executive Director at China Huajun Group Ltd., an Independent Non-Executive Director at Alphamab Oncology and a Chairman at GemPharmatech Co., Ltd. He is on the Board of Directors at China Huajun Group Ltd. and Alphamab Oncology.
He received his undergraduate degree from Nanjing University, a graduate degree from Nanjing University and a doctorate degree from Thomas Jefferson University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-09-2026 | 196.417.185 ( 47,91% ) | 1 111 M $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| GEMPHARMATECH CO., LTD. | Oprichter | 29-12-2017 |
| ALPHAMAB ONCOLOGY | Directeur/Bestuurslid | 30-06-2025 |
| CHINA HUAJUN GROUP LIMITED | Directeur/Bestuurslid | 01-09-2026 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Thomas Jefferson University
Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Huajun Group Ltd.
China Huajun Group Ltd. Pulp & PaperProcess Industries Manufactures and prints printing, packaging and paper products | Process Industries |
Nanjing University
Nanjing University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GemPharmatech Co., Ltd.
GemPharmatech Co., Ltd. BiotechnologyHealth Technology Specializing in the research and development of humanized models and drug screening technologies | Health Technology |
Alphamab Oncology
Alphamab Oncology BiotechnologyHealth Technology Operates as biopharmaceutical company which engages in development manufacturing and commercialization of therapeutics for cancer treatment | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau